Background: Helicobacter pylori prevalence varies greatly worldwide. We explored the prevalence of H. pylori and CagA seropositivity among adults aged 18-44 years living in the Netherlands by ethnicity and migration status (first vs second generation).
Materials and Methods:Participants from six different ethnic groups were selected from the population-based multi-ethnic HELIUS study in Amsterdam, the Netherlands. Serum samples were tested for H. pylori antigens using a validated Luminex-based multiplex serology assay. Prevalence ratios were estimated using Poisson regression analysis.
Results:A total of 4683 participants aged 18-44 years were randomly selected based on sex, ethnicity, and age. H. pylori seroprevalence was highest in the Ghanaian group (84%), followed by Moroccan (81%), Turkish (66%), African Surinamese (51%), South-Asian Surinamese (48%), and Dutch (17%) participants. All ethnic minority groups had a significantly higher risk of being H. pylori seropositive compared to the Dutch group.This association was strongest among participants born outside the Netherlands (first generation), but was still significant and apparent among second-generation participants. Among first-generation participants, all groups, except the Moroccans, had a significantly higher proportion of individuals with a cagA + H. pylori strain compared to the Dutch participants.
Conclusion:Helicobacter pylori seroprevalence among first-generation migrants is high in the Netherlands and remains elevated among second-generation migrants (ie, those born in the Netherlands). High exposure to H. pylori, and especially to the more virulent cagA+ strain, highlights the need for tailored prevention of gastric diseases (notably peptic ulcers and cancers) among migrants.
K E Y W O R D Scross-sectional study, ethnicity, general population, Helicobacter pylori, migrants, seroprevalence 2 of 14 | ALBERTS ET AL.
| INTRODUC TI ONThe bacterium Helicobacter pylori has been identified as a strong risk factor for severe diseases, including peptic ulcer disease, noncardia gastric cancer, and gastric lymphoma. 1-3 H. pylori is the most impactful infectious agent causing cancer worldwide, that is, 810 000 (37%) of the 2.2 million cancers attributable to infectious diseases in the year 2018. 4,5 In western countries, despite the decrease in H. pylori prevalence observed among younger generations, H. pylori is responsible for half the burden of all infection-related cancers. 4 Although incidence rates of gastric cancer are low in most developed countries, 6 mortality rates are high as cancer cases are usually diagnosed at a late stage. 7 Furthermore, the risk of noncardia gastric cancer has been shown to be significantly elevated among migrant populations. 8 H. pylori can be effectively treated using a combination of antimicrobial drugs given orally for 7-14 days. 9 No worldwide consensus currently exists on testing and treatment of H. pylori to prevent the burden of diseases caused by this chronic infection. 10,11 To be able to make projections on futu...